Table 3.
Total Congenital Heart Defects (Ncases = 474) | Ventricular Septal Defects (Ncases = 222) | Atrial Septal Defects (Ncases = 218) | |||||
---|---|---|---|---|---|---|---|
Ncases/Ncontrols | Unadjusted OR (95%CI) |
Adjusted OR (95%CI) 1 |
Unadjusted OR (95%CI) |
Adjusted OR (95%CI) 1 |
Unadjusted OR (95%CI) |
Adjusted OR (95%CI) 1 |
|
GDQS | |||||||
Quartile 1 | 218/218 | 1 | 1 | 1 | 1 | 1 | 1 |
Quartile 2 | 131/241 | 0.54 (0.41, 0.72) | 0.59 (0.42, 0.82) | 0.51 (0.35, 0.74) | 0.51 (0.32, 0.79) | 0.57 (0.39, 0.83) | 0.51 (0.34, 0.79) |
Quartile 3 | 75/237 | 0.32 (0.23, 0.44) | 0.36 (0.24, 0.53) | 0.35 (0.23, 0.52) | 0.38 (0.23, 0.63) | 0.39 (0.26, 0.59) | 0.35 (0.21, 0.59) |
Quartile 4 | 50/252 | 0.20 (0.14, 0.28) | 0.26 (0.16, 0.42) | 0.18 (0.11, 0.29) | 0.23 (0.12, 0.44) | 0.21 (0.13, 0.34) | 0.21 (0.11, 0.41) |
p for trend | 474/948 | <0.001 | <0.001 | <0.001 | <0.001 | <0.001 | <0.001 |
Per 1 higher score | 474/948 | 0.87 (0.85, 0.89) | 0.88 (0.85, 0.91) | 0.87 (0.84, 0.90) | 0.88 (0.84, 0.92) | 0.88 (0.85, 0.91) | 0.87 (0.84, 0.91) |
MDS | |||||||
Quartile 1 | 142/164 | 1 | 1 | 1 | 1 | 1 | 1 |
Quartile 2 | 159/271 | 0.67 (0.50, 0.91) | 0.76 (0.54, 1.08) | 0.68 (0.46, 1.01) | 0.87 (0.55, 1.38) | 0.80 (0.53, 1.19) | 0.83 (0.53, 1.31) |
Quartile 3 | 75/162 | 0.53 (0.37, 0.76) | 0.70 (0.46, 1.08) | 0.62 (0.39, 0.98) | 0.81 (0.52, 1.26) | 0.69 (0.43, 1.11) | 0.80 (0.47, 1.36) |
Quartile 4 | 98/351 | 0.32 (0.23, 0.44) | 0.53 (0.34, 0.83) | 0.34 (0.22, 0.52) | 0.57 (0.34, 0.96) | 0.44 (0.28, 0.67) | 0.61 (0.38, 0.97) |
p for trend | 474/948 | <0.001 | 0.007 | <0.001 | 0.010 | <0.001 | 0.016 |
Per 1 higher score | 474/948 | 0.79 (0.75, 0.84) | 0.88 (0.80, 0.95) | 0.80 (0.74, 0.87) | 0.89 (0.81, 0.98) | 0.85 (0.78, 0.91) | 0.90 (0.83, 0.98) |
GDQS, Global Diet Quality Score; MDS, Mediterranean Diet Score. 1 Adjusted for total energy intake during pregnancy sociodemographic characteristics (maternal age, work, education, residence, and parity), and maternal health-related factors in early pregnancy (passive smoking, anemia, medication use, and folate/iron supplements use).